Insider trades

Reardon Andrew

Reardon Andrew made 0 buys and 62 sales on the open market in the last 12 months at Ligand Pharmaceuticals Incorporated. Each trade with the role, price and filing.

DateCompanyTradeSharesPrice
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale708US$308.43
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale522US$309.91
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale490US$310.61
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale520US$311.72
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale634US$312.85
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale403US$313.75
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale80US$314.58
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale280US$317.91
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale440US$318.73
Nov 2, 2026Ligand Pharmaceuticals IncorporatedSale320US$319.97